Kavveri Defence & Wireless Technologies Limited (BOM:590041)

Ligand Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	143.51	14.48	2.27	2.83	4.24
Cash & Short-Term Investments	143.51	14.48	2.27	2.83	4.24
Cash Growth	891.21%	539.21%	-19.94%	-33.22%	-89.18%
Accounts Receivable	78.14	45.45	16.87	498.63	389.3
Other Receivables	-	1.47	7.8	37.13	36.21
Receivables	78.14	46.91	24.68	535.75	425.51
Inventory	31.21	14.98	16.48	577.59	578.51
Prepaid Expenses	-	-	-	0.13	0.01
Other Current Assets	218.22	206	223.47	483.78	706.86
Total Current Assets	471.07	282.37	266.9	1,600	1,715
Property, Plant & Equipment	19.78	15.14	15.39	52.67	71.48
Long-Term Investments	213.86	214.41	208.06	-	-
Other Intangible Assets	0.38	2.05	3.91	5.23	6.9
Long-Term Deferred Tax Assets	-	-	-	139.94	166.16
Other Long-Term Assets	258.97	340.06	295.96	949.08	889.36
Total Assets	1,235	854.03	790.22	2,747	2,849
Accounts Payable	61.91	52.72	105.51	149.95	131.15
Accrued Expenses	24.51	64.79	71.56	32.72	30.64
Short-Term Debt	189.26	-	0.34	2,080	2,002
Current Portion of Long-Term Debt	-	-	-	28.91	26.92
Current Income Taxes Payable	-	23.14	23.31	23.26	23.26
Other Current Liabilities	90.9	243.04	66.99	66.92	57.75
Total Current Liabilities	366.57	383.68	267.71	2,382	2,272
Long-Term Debt	-	-	-	17.01	66.41
Other Long-Term Liabilities	-	-	-	218.74	224.14
Total Liabilities	366.57	383.68	267.71	2,623	2,562
Common Stock	201.24	201.24	201.24	201.24	201.24
Additional Paid-In Capital	-	-	1,180	1,180	1,180
Retained Earnings	-	-	-866.09	-1,255	-1,074
Comprehensive Income & Other	667.13	269.1	7.33	-2.36	-20.05
Total Common Equity	868.37	470.34	522.52	123.74	286.97
Shareholders' Equity	868.37	470.34	522.52	123.74	286.97
Total Liabilities & Equity	1,235	854.03	790.22	2,747	2,849
Total Debt	189.26	-	0.34	2,126	2,095
Net Cash (Debt)	-45.75	14.48	1.93	-2,123	-2,091
Net Cash Growth	-	650.54%	-	-	-
Net Cash Per Share	-1.11	0.72	0.10	-105.52	-103.90
Filing Date Shares Outstanding	20.15	20.12	20.12	20.12	20.12
Total Common Shares Outstanding	20.15	20.12	20.12	20.12	20.12
Working Capital	104.51	-101.31	-0.81	-782.02	-556.38
Book Value Per Share	43.09	23.37	25.96	6.15	14.26
Tangible Book Value	867.99	468.29	518.61	118.51	280.07
Tangible Book Value Per Share	43.08	23.27	25.77	5.89	13.92
Construction In Progress	-	-	-	-	5.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.